Thousands of lawsuits have been filed against some of the largest manufacturers of IVC Filters, which are designed to trap blood clots passing through arteries and heading for the lungs. Now, litigation against one of the smaller manufacturers of these devices, Cordis Corporation, is picking up steam.
Cordis Trap OptEase and TrapEase In Crosshairs for IVC Filter Litigation
Cordis Corporation makes the Trap OptEase and the TrapEase IVC filters. These metal alloy implants, which are inserted into the heart’s vena cava and extend spider-like legs out in order to capture clots, are meant to prevent patients from suffering pulmonary embolisms. Unfortunately, many recipients of Cordis IVC Filters have allegedly experienced life-threatening injuries due to the devices.
Litigation against Cordis Moves Forward in Florida
In part, the severe injuries suffered by some patients, including perforation of organs, has been the result of delayed removal. The filters were designed to be removed after 30-60 days. However, some devices have been left in patients for much longer, causing serious health problems. Several cases against Cordis Corporation are now pending in Florida courts.
Adverse Effects of IVC Filters
According to the FDA, the resulting adverse effects can involve complications such as:
- Filter fracture
- Embolization of broken components
- Migration and tilt
- Organ damage (heart, lungs, kidneys, etc.)
- Perforation of the vena cava
- Internal bleeding
- Deep Vein Thrombosis (DVT)
- Filter is clogged with blood clots
- Filter or Broken pieces can’t be removed
IVC Filter devices involved in the lawsuits:
- Cook Celect Filter
- Cook Gunther Tulip Filter
- Bard Recovery Filter
- Bard G2 Filter
- Bard G2 Express Filter
- Cordis TrapEase